Varex Imaging Corporation (VREX)
Nasdaq · Healthcare · Medical Devices
$18.45−0.05%as of Oct 6, 2026, 1:35 AM ET
- Market cap
- $784M
- P/E (trailing)
- 34.8
- Forward P/E
- 17.2
- 52-week range
- $9.09 – $18.63
- 52-week change
- +59.69%
- EPS (trailing)
- $0.53
- Next earnings
- Nov 17, 2026
Fiscal year to Oct 2025
- Revenue
- $845M (+4.14%)
- Net income
- −$70.3M
- Operating margin
- −3.3%
- Diluted EPS
- −$1.70
- Free cash flow
- $18.8M
From the company’s annual report on SEC EDGAR.
About Varex Imaging Corporation
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications.
Headquarters: Salt Lake City, United States · 2,500 employees · vareximaging.com